EASD Congress
24 September

Open Chat Forum

Below is a public chat window where you can engage with other guests throughout the congress period. Please note that all posts are visible to all users on this site and cannot be deleted.

Engage with guests using the One on One video chat feature. Just select the guest name settings to open up a video window and connect. You can also use the settings cog to open in a new window and the power button to logout.

Online eCafe'

Take a moment and join us at our private eCafé meeting room during the EASD sessions where you can engage with local, fellow experts and Servier representatives.

Please join us between

Conference ID: 456 673 67#

13:45 -14:45

Days
Hours
Minutes
Seconds

Dr Amod

Prof Joel Dave

EASD Topics of Interest

24th September 2020

08h30 The important conversation between the heart and the kidney Graz Hall
10h15-11-45 Reduction of carrdiovascular events by GLP-1 receptor agonists is explained by HbA1c reduction Vienna Hall
17h15 New approaches to reducing hypoglycaemia: hype or hope Linz Hall
17h15 Do we need surveillance of the liver of type 2 diabetes patients? Villach Hall
17h15 New approaches to reducing hypoglycaemia: hype or hope Linz Hall

Poster Presentations

13:15 – 14:15

PS 48 – Various clinical aspects of incretin-based

600 – Very low dose gliclazide lowers blood glucose by increasing incretin effect and beta-cell glucose sensitivity

Authors: R.L.M Cordiner (United Kingdom), A. Mari (Italy), A. Tura (Italy), E.R. Pearson (United Kingdom)

Medical Affairs Digital Activities

Terms and Conditions

1. Servier values your professional independence. Our support is not conditional upon any obligation for you to use, recommend, promote or purchase Servier products. 2. By accepting this invitation you agree to comply with all applicable laws and regulations, including any obligation to obtain an authorisation to attend the event or to declare your participation to this event, as well as any transparency requirements according to applicable laws and regulations in your country of practice. 3. Registration will be on a first come first serve basis. 4. You hereby acknowledge that legislation requires and therefore Servier’s internal compliance records must reflect specific data (*) for the purposes of (a) HPCSA CPD accreditation and (b) BEE legislation, regarding the interaction between the Company and each specific HCP. Your data will be kept for these purposes and will not be sold or used for any other purpose than these.

SERVIER LABORATORIES SOUTH AFRICA (Pty) Ltd.

Reg. No. 72/14307/07. Building Number 4,
Country Club Estate, 21 Woodlands Drive,
Woodmead, 2191.
P.O. Box 930, Rivonia, 2128,
Republic of South Africa.
TEL: +27 (0) 861 700 900.
FAX: +27(0)11 525 3401.